HighTower Advisors LLC grew its position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report) by 33.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 29,619 shares of the real estate investment trust’s stock after acquiring an additional 7,403 shares during the period. HighTower Advisors LLC’s holdings in Sabra Health Care REIT were worth $547,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in SBRA. Family Firm Inc. purchased a new stake in shares of Sabra Health Care REIT during the 2nd quarter worth $26,000. Assetmark Inc. lifted its stake in shares of Sabra Health Care REIT by 168.4% in the third quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust’s stock valued at $37,000 after purchasing an additional 1,231 shares during the period. Harbor Capital Advisors Inc. purchased a new stake in Sabra Health Care REIT during the third quarter worth about $78,000. GAMMA Investing LLC boosted its holdings in Sabra Health Care REIT by 25.3% during the third quarter. GAMMA Investing LLC now owns 4,614 shares of the real estate investment trust’s stock worth $86,000 after buying an additional 932 shares in the last quarter. Finally, International Assets Investment Management LLC grew its position in Sabra Health Care REIT by 1,761.0% during the third quarter. International Assets Investment Management LLC now owns 6,104 shares of the real estate investment trust’s stock worth $114,000 after buying an additional 5,776 shares during the period. 99.40% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
SBRA has been the topic of a number of analyst reports. Scotiabank increased their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a report on Friday, October 11th. Mizuho reissued a “neutral” rating and issued a $20.00 price target on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Truist Financial lifted their price objective on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Citigroup upgraded shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and upped their target price for the stock from $17.00 to $20.00 in a research report on Friday, September 13th. Finally, Wells Fargo & Company upgraded Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $16.00 to $20.00 in a research report on Tuesday, October 1st. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $19.14.
Sabra Health Care REIT Price Performance
Shares of Sabra Health Care REIT stock opened at $16.96 on Friday. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16. The company has a market cap of $4.01 billion, a PE ratio of 41.37, a price-to-earnings-growth ratio of 2.20 and a beta of 1.24. The firm has a fifty day moving average price of $18.46 and a two-hundred day moving average price of $17.15. Sabra Health Care REIT, Inc. has a fifty-two week low of $12.83 and a fifty-two week high of $20.03.
Sabra Health Care REIT (NASDAQ:SBRA – Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.22). The company had revenue of $178.00 million for the quarter, compared to analyst estimates of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same period in the prior year, the company posted $0.34 EPS. Analysts expect that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current year.
Sabra Health Care REIT Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.08%. The ex-dividend date was Friday, November 15th. Sabra Health Care REIT’s dividend payout ratio is presently 292.68%.
About Sabra Health Care REIT
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
Recommended Stories
- Five stocks we like better than Sabra Health Care REIT
- Following Congress Stock Trades
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Stock Market Sectors: What Are They and How Many Are There?
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- What is a Stock Market Index and How Do You Use Them?
- 2 Underrated Quantum Computing Companies Starting to Rally
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report).
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.